Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2007-11-15 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CLICHY (92110), Hauts-de-Seine
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE EUROPEENNE DE CLICHY : revenue, balance sheet and financial ratios
SELARL PHARMACIE EUROPEENNE DE CLICHY is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CLICHY (92110),
this company of category PME
shows in 2015 a revenue of 524 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE EUROPEENNE DE CLICHY (SIREN 501441869)
Indicator
2024
2023
2018
2017
2016
2015
Revenue
N/C
N/C
N/C
N/C
N/C
524 163 €
Net income
144 833 €
-281 202 €
15 996 €
15 492 €
14 267 €
20 970 €
EBITDA
N/C
N/C
N/C
N/C
N/C
24 566 €
Net margin
N/C
N/C
N/C
N/C
N/C
4.0%
Revenue and income statement
In 2024, SELARL PHARMACIE EUROPEENNE DE CLICHY generates positive net income of 145 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2024: 21 k€ -> 145 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
144 833 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at -2467%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -3%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
-2467.47%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
-3.263%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE EUROPEENNE DE CLICHY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2023
2024
Debt ratio
-685.18
-3210.946
708.301
456.938
-701.616
-2467.47
Financial autonomy
-11.09
-2.103
6.501
12.484
-12.884
-3.263
Repayment capacity
4.845
None
None
None
None
None
Cash flow / Revenue
4.486%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
-2467.472024
2018
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent-50 pts over 3 years
In 2024, the debt ratio of SELARL PHARMACIE EUROPEEN... (-2467.47) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
-3.26%2024
2018
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of SELARL PHARMACIE EUROPEEN... (-3.3%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 191.25. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
191.25
Liquidity indicators evolution SELARL PHARMACIE EUROPEENNE DE CLICHY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2023
2024
Liquidity ratio
123.265
126.897
121.275
176.873
166.275
191.25
Interest coverage
6.623
None
None
None
None
None
Sector positioning
Liquidity ratio
191.252024
2018
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good
In 2024, the liquidity ratio of SELARL PHARMACIE EUROPEEN... (191.25) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE EUROPEENNE DE CLICHY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2023
2024
Operating WCR
63 219 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
36
0
0
0
0
0
Customer payment term (days)
8
0
0
0
0
0
Supplier payment term (days)
40
0
0
0
0
0
Positioning of SELARL PHARMACIE EUROPEENNE DE CLICHY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE EUROPEENNE DE CLICHY is estimated at
2 021 975 €
(range 1 408 071€ - 3 024 991€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1408k€2021k€3024k€
2 021 975 €Range: 1 408 071€ - 3 024 991€
NAF 5 année 2024
Valuation method used
Net Income Multiple
144 833 €
×
14.0x
=2 021 976 €
Range: 1 408 072€ - 3 024 991€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE EUROPEENNE DE CLICHY with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE EUROPEENNE DE CLICHY
What is the revenue of SELARL PHARMACIE EUROPEENNE DE CLICHY ?
The revenue of SELARL PHARMACIE EUROPEENNE DE CLICHY in 2015 is 524 k€.
Is SELARL PHARMACIE EUROPEENNE DE CLICHY profitable?
Yes, SELARL PHARMACIE EUROPEENNE DE CLICHY generated a net profit of 145 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE EUROPEENNE DE CLICHY ?
The headquarters of SELARL PHARMACIE EUROPEENNE DE CLICHY is located in CLICHY (92110), in the department Hauts-de-Seine.
Where to find the tax return of SELARL PHARMACIE EUROPEENNE DE CLICHY ?
The tax return of SELARL PHARMACIE EUROPEENNE DE CLICHY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE EUROPEENNE DE CLICHY operate?
SELARL PHARMACIE EUROPEENNE DE CLICHY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart